Denali Therapeutics Inc. (DNLI)

CIK 1714899 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Denali Therapeutics Inc..

Recent SEC filings

FiledFormAccession number
Sep 9, 202640002124755-26-000007
Sep 4, 202640001797826-26-000006
Sep 4, 20261440002124755-26-000006
Sep 3, 202640001724311-26-000014
Sep 2, 20261440001950047-26-009017
Sep 1, 20261440001950047-26-008944
Aug 14, 202640001724310-26-000007
Aug 13, 202640001724311-26-000013
Aug 11, 20261440001724311-26-000012
Aug 6, 202610-Q0001714899-26-000097
Aug 6, 20268-K0001714899-26-000096
Aug 4, 2026SCHEDULE 13G/A0001088875-26-000056
Jul 28, 20268-K0001714899-26-000086
Jul 8, 2026SCHEDULE 13G/A0001897612-26-000525
Jun 18, 20268-K0001714899-26-000081
Jun 5, 202640001478007-26-000002
Jun 5, 202640001193125-26-259680
Jun 5, 202640001666236-26-000015
Jun 5, 202640001578200-26-000004
Jun 5, 202640001816206-26-000003
Jun 5, 202640001754371-26-000002
Jun 5, 202640001189130-26-000005
Jun 5, 202640001797826-26-000002
Jun 4, 20268-K0001714899-26-000074
May 22, 20268-K0001714899-26-000070